By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Capricor Therapeutics, Inc. 

8700 Beverly Boulevard
Davis Building - Room D-1063
Los Angeles  California  90048  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Capricor Therapeutics, Inc. To Participate In Two Upcoming Investor Conferences In June 5/27/2015 7:15:19 AM
Capricor Therapeutics, Inc. Reports First Quarter 2015 Financial & Business Highlights 5/13/2015 10:42:24 AM
Capricor Therapeutics, Inc. To Hold First Quarter 2015 Business Update And Financial Results Conference Call On May 12, 2015 At 4:30 P.M. EDT 5/6/2015 7:51:48 AM
Capricor Therapeutics, Inc. Granted FDA Orphan Drug Designation For Allogeneic Cardiosphere-Derived Cells For The Treatment Of Duchenne Muscular Dystrophy 4/22/2015 8:18:12 AM
Capricor Therapeutics, Inc. Completes Enrollment Of Initial Phase Of DYNAMIC Clinical Trial Of Cardiosphere-Derived Cell Therapy For Treatment Of Advanced Heart Failure 4/8/2015 7:20:02 AM
CryoPort, Inc. Expands Logistics Support To Capricor Therapeutics, Inc.'s DYNAMIC Clinical Trial For Heart Failure 4/7/2015 9:55:12 AM
Capricor Therapeutics, Inc. Completes Enrollment Of Phase II Clinical Trial For Cenderitide To Treat Heart Failure 3/31/2015 6:31:24 AM
Capricor Therapeutics, Inc. To Present At 3rd Annual Regen Med Investor Day On March 25, 2015 In New York 3/23/2015 9:22:34 AM
Capricor Therapeutics, Inc. Reports Fourth Quarter And Full Year 2014 Financial & Business Highlights 3/19/2015 8:30:58 AM
Capricor Therapeutics, Inc. To Hold Fourth Quarter 2014 Business Update Conference Call On March 18, 2015 At 4:30 P.M. EDT 3/12/2015 7:47:36 AM
12345
//-->